| 764178 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
940 Targeting DKK1 to reverse immunosuppressive macrophages and enhance PD-1 blockade therapy in gastric cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.940 |
Shi Tao, Zhang Yipeng, Wang Yue, Pan Yunfeng, Wang Hanbing, Luo Yuting, Liang Kaijie, Liu Fangcen, Liu Qin, Che Keying, Wang Xuan, Yu Lixia, Liu Baorui, Wei Jia |
| 764177 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
939 Autocrine/paracrine factors in cancer associated fibroblasts drive immunosuppression through impaired myeloid cell functions |
2021-11-01 |
10.1136/jitc-2021-sitc2021.939 |
Sharma Nikita, Govindaraju Priya, Bradford Shermineh, Wang Yarong, Flynn Brianna, Sze Lei Candace Wai, Blasi Varenka Rodriguez Di, Pignatelli Jeanine, Liu Kang, Corse Emily, Kashyap Abhishek |
| 764176 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
938 Study of the tumor microenvironment of oral squamous cell carcinoma using multiplex immunofluorescence and image analysis approaches |
2021-11-01 |
10.1136/jitc-2021-sitc2021.938 |
Rojas Frank, Bouaoud Jebrane, Parra Edwin, Saintigny Pierre, Tamegnon Auriole, Jiang Mei, Zhang Shanyu, Renganayaki Pandurengan, Michon Lucas, Gadot Nicolas, Lantuejoul Sylvie, Zrounba Philippe, Foy Jean-Philippe, Mahtouk Karene, Bertolus Chloe |
| 764175 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
937 Advanced understanding of the tumor microenvironment with multiplex analysis: an automated 7-color multiplex assay using Akoya’s opal technology |
2021-11-01 |
10.1136/jitc-2021-sitc2021.937 |
Patel Bhavika, Allen Stephanie, Eliseeva Tania, Mammadova Najiba, Haggerty Agnes, Mehra Navi |
| 764174 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
936 Stromal remodeling regulates dendritic cell abundance in the tumor microenvironment |
2021-11-01 |
10.1136/jitc-2021-sitc2021.936 |
Papadas Athanasios, Deb Gauri, Officer Adam, Hope Chelsea, Emmerich Philip, Cicala Alexander, Wiesner Joshua, Arauz Garrett, Pagenkopf Adam, Matkowskyj Kristina, Deming Dustin, Politi Katerina, Abrams Scott, Harismendy Olivier, Asimakopoulos Fotis |
| 764173 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
935 Attraction of immune cells by head and neck cancer cell lines and primary tumor-conditioned supernatants |
2021-11-01 |
10.1136/jitc-2021-sitc2021.935 |
Muijlwijk Tara, Remkes Naomi, Poell Jos, Leemans René, Brakenhoff Ruud, Ven Rieneke van de |
| 764172 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
934 Biological mechanisms in the different etiologies of Merkel cell carcinoma patients: polyomavirus or UV exposure |
2021-11-01 |
10.1136/jitc-2021-sitc2021.934 |
Mallardo Domenico, Scognamiglio Giosuè, North Khrystyna, Capone Mariaelena, Bailey Michael, Scarpato Luigi, Church Sarah, Madonna Gabriele, Reeves Jason, Curvietto Marcello, Tuffanelli Marilena, d’angelo grazia, Simeone Ester, Festino Lucia, Vanella Vito, Trojaniello Claudia, Vitale Maria Grazia, Tafuto Salvatore, Caracò Corrado, Anniciello Anna Maria, Normanno Nicola, Bonito Maurizio Di, Warren Sarah, Ascierto Paolo |
| 764171 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
933 Immune infiltrates differences between central and periphery regions of colorectal and pancreas adenocarcinomas |
2021-11-01 |
10.1136/jitc-2021-sitc2021.933 |
Maia Andreia, Lérias Joana, Borrego Luis Miguel, Maeurer Markus, Castillo-Martin Mireia |
| 764170 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
440 A Phase II study of eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab in patients unselected for PD-L1 expression in first line metastatic head and neck squamous cell carcinoma (HNSCC) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.440 |
Peguero Julio, Triebel Frederic |
| 764169 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
18 Systemic immune profiling of advanced biliary tract cancer patients defines altered cytokines and immune cell populations |
2021-11-01 |
10.1136/jitc-2021-sitc2021.018 |
Ruggieri Amanda, Yarchoan Mark, Liu Yuan, Goyal Subir, Sharon Elad, Chen Helen, Olson Brian, Maithel Shishir, El-Rayes Bassel, Azad Nilofer, Lesinski Gregory |
